pLX313-Firefly luciferase Citations (5)
Originally described in: Mutational processes shape the landscape of TP53 mutations in human cancer.Giacomelli AO, Yang X, Lintner RE, McFarland JM, Duby M, Kim J, Howard TP, Takeda DY, Ly SH, Kim E, Gannon HS, Hurhula B, Sharpe T, Goodale A, Fritchman B, Steelman S, Vazquez F, Tsherniak A, Aguirre AJ, Doench JG, Piccioni F, Roberts CWM, Meyerson M, Getz G, Johannessen CM, Root DE, Hahn WC Nat Genet. 2018 Oct;50(10):1381-1387. doi: 10.1038/s41588-018-0204-y. PubMed Journal
Articles Citing pLX313-Firefly luciferase
| Articles |
|---|
| Phosphate dysregulation via the XPR1-KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer. Bondeson DP, Paolella BR, Asfaw A, Rothberg MV, Skipper TA, Langan C, Mesa G, Gonzalez A, Surface LE, Ito K, Kazachkova M, Colgan WN, Warren A, Dempster JM, Krill-Burger JM, Ericsson M, Tang AA, Fung I, Chambers ES, Abdusamad M, Dumont N, Doench JG, Piccioni F, Root DE, Boehm J, Hahn WC, Mannstadt M, McFarland JM, Vazquez F, Golub TR. Nat Cancer. 2022 Jun;3(6):681-695. doi: 10.1038/s43018-022-00360-7. Epub 2022 Apr 18. PubMed |
| Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain Metastases. Kieliszek AM, Mobilio D, Upreti D, Bloemberg D, Escudero L, Kwiecien JM, Alizada Z, Zhai K, Ang P, Chafe SC, Vora P, Venugopal C, Singh SK. Clin Cancer Res. 2024 Feb 1;30(3):554-563. doi: 10.1158/1078-0432.CCR-23-1735. PubMed |
| De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases. Kieliszek AM, Mobilio D, Bassey-Archibong BI, Johnson JW, Piotrowski ML, de Araujo ED, Sedighi A, Aghaei N, Escudero L, Ang P, Gwynne WD, Zhang C, Quaile A, McKenna D, Subapanditha M, Tokar T, Vaseem Shaikh M, Zhai K, Chafe SC, Gunning PT, Montenegro-Burke JR, Venugopal C, Magolan J, Singh SK. Cell Rep Med. 2024 Oct 15;5(10):101755. doi: 10.1016/j.xcrm.2024.101755. Epub 2024 Oct 4. PubMed |
| GRHL2-HER3 and E-cadherin mediate EGFR-bypass drug resistance in lung cancer cells. Ito F, Iwata W, Adachi Y, Sesaki H, Iijima M. Front Cell Dev Biol. 2025 Jan 17;12:1511190. doi: 10.3389/fcell.2024.1511190. eCollection 2024. PubMed |
SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO.
Borck PC, Boyle I, Jankovic K, Bick N, Foster K, Lau AC, Parker-Burns LI, Lubicki DA, Li T, Borah AA, Lofaso NJ, Das Sharma S, Chan T, Kishen RV, Adeagbo A, Raghavan S, Aquilanti E, Prensner JR, Krill-Burger JM, Golub TR, Campbell CD, Dempster JM, Chan EM, Vazquez F.
Nature. 2025 Feb 5. doi: 10.1038/s41586-024-08509-3.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.